Cargando…
Ubiquitination in Scleroderma Fibrosis and Its Treatment
Scleroderma (systemic sclerosis, SSc) is a highly heterogeneous rheumatic disease, and uncontrolled fibrosis in visceral organs is the major cause of death in patients. The transforming growth factor-β (TGF-β) and WNT/β-catenin signaling pathways, along with signal transducer and activator of transc...
Autores principales: | Long, Ying, Chen, Weilin, Du, Qian, Zuo, Xiaoxia, Zhu, Honglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199354/ https://www.ncbi.nlm.nih.gov/pubmed/30386338 http://dx.doi.org/10.3389/fimmu.2018.02383 |
Ejemplares similares
-
MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma
por: Zhu, Honglin, et al.
Publicado: (2013) -
The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis
por: Meng, Meng, et al.
Publicado: (2019) -
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis
por: Palisoc, Pamela J., et al.
Publicado: (2022) -
Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis
por: Cantanhede, Isabella Gomes, et al.
Publicado: (2022) -
The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma
por: Kavian, Niloufar, et al.
Publicado: (2018)